Authors
Loading...
This research demonstrates that biomimetic nanoparticles improve antitumor immunity in hepatocellular carcinoma, highlighting the role of extracellular ATP and targeting myeloid-derived suppressor cells.
Lan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: